01 March 2001
Mechanisms of action of the new anti-epileptic drugs
Barbara ChmielewskaCase Rep Clin Pract Rev 2001; 2(1):70-76 :: ID: 474657
Abstract
Conventional drugs provide appropriate protection to ca 2/3 of patients with epilepsy and are responsible for numerous side effects, especially in polytherapy. The recent findings concerning synaptic and membranous mechanisms of epileptogenesis, and, in particular, the significance of reduced inhibitory GABA-ergic neurotransmission and changes in membranous conductivity of sodium and calcium ions, have contributed during the last decade to the development of numerous novel antiepileptic drugs. Among those, vigabatrin, lamotrigine, gabapentin, tiagabine, felbamate and topiramate are the best known and most promising novel drugs. Lamotrigine, like traditional drugs - phenytoin and carbamazepine - limits the spread of convulsive activity by blocking the activity of sodium channels. Vigabatrin, gabapentin and tiagabine enhance the effect of GABA-ergic inhibition, similarly to phenobarbital and benzodiazepines. Felbamate and topiramate demonstrate multidirectional activity, modifying both inhibitory and excitatory synaptic processes. The novel drugs, currently used primarily in the cases of drug-resistant epilepsy, have extended the scope of available effective treatment, being additionally well-tolerated by the patients owing to their favorable pharmacokinetic properties.
Keywords: Epilepsy, novel drugs, mechanisms of activity
19
In Press
12 Feb 2024 : Case report
Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PETAm J Case Rep In Press; DOI: 10.12659/AJCR.941169
12 Feb 2024 : Case report
Surgical Treatment of Spontaneous Superficial Temporal Artery Arteriovenous Malformation: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942839
13 Feb 2024 : Case report
Warfarin Woes: A Rare Case of Hemoperitoneum with Intramural Small Bowel HematomaAm J Case Rep In Press; DOI: 10.12659/AJCR.943519
13 Feb 2024 : Case report
Hemorrhagic Presentation in Primary Central Nervous System Lymphoma: A Case StudyAm J Case Rep In Press; DOI: 10.12659/AJCR.942951
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250